Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HARMONY 3: Albiglutide vs Active Controls in T2D
NCT00838903Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2009
- Primary completion
- Jan 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 11
01
Overview
A Phase 3 trial of albiglutide in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Feb 2009; status: completed.
02
Drugs
albiglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00838903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00838903.